CMA urges federal government to maintain health funding

Prime Minister Mark Carney warned ahead of the 2025 federal budget that “sacrifices” must be made. That's why, as government is set to unveil the budget tomorrow, the Canadian Medical Association (CMA) is urging federal leaders to protect the health transfers that are critical for funding health care across Canada. Physicians, like all Canadians, understand […]

Workers have a say on digital rules through collective bargaining

A news report from China Daily: A nationwide initiative led by the All-China Federation of Trade Unions has made strides this year, using a “centralized collective bargaining” campaign between platform companies and their workers. https://mma.prnewswire.com/media/2811322/Delivery_riders_from_Meituan_deliver_food_in_Shenyang__Liaoning_province.jpg The campaign brings platform companies – businesses that coordinate work through digital apps – to the table to negotiate the

GC Biopharma’s Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in ‘Vaccine’

GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been published in the international journalVaccine. BARYTHRAX is the world's first recombinant anthrax vaccine, jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency

Black Friday Outlook: 79% of Consumers Plan to Shop as GenAI Usage Spikes

— As Awareness of Year-End Sales Events Climbs, Nearly Half of Consumers Plan to Use GenAI to Shop-Up 9 Points Over 2024 — Consumers Intend to Spend Strategically During Year-End Sales to Maximize Value, Even As 81% Cite Concerns Around Rising Prices for Essentials and 71% Around Tariff-Related Price Increases — BCG Survey Finds Winning

IONX and Virgin Media O2: A UK First for 5G Standalone

IONX Networks and Virgin Media O2 (VMO2) have reached a significant milestone in the evolution of UK mobile connectivity by successfully integrating a neutral host small cell into VMO2's live 5G Standalone (SA) core network, a first-of-its-kind deployment in the UK. https://mma.prnewswire.com/media/2810794/IONX_Networks.jpg This breakthrough strengthens VMO2's commitment to delivering next-generation 5G services closer to customers,

HTX Wins “Web3 Venture Capital Fund of the Year” Award at Blockchain Life 2025

Global leading cryptocurrency exchange HTX made a commanding appearance at Blockchain Life 2025 in Dubai from October 28-29, serving as a Sapphire sponsor. The two-day summit gathered leaders, institutional investors, and innovators from blockchain, cryptocurrency, Web3, and mining sectors across more than 100 countries, to explore the latest trends shaping the future of the crypto

Akeso’s Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer

Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) from China's National Medical Products Administration (NMPA). The Phase III multicenter, randomized, double-blind clinical trial (HARMONi-BC1/AK112-308) for

Legal Innovation Asia 2026 Report Reveals GenAI Transforming Legal Work, But Human Expertise Remains Central

Generative AI is transforming legal work Technology adoption depends on education, and leadership buy-in Technology matters – but people skills matter more A newly released report, Legal Innovation Asia 2026: AI Meets Law – The Next Frontier, highlights how generative AI is reshaping the roles of legal professionals, and how prepared Asia's legal sector is

VFC Investors have Opportunity to Lead V.F. Corporation Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofV.F. Corporation (NYSE: VFC) between October 30, 2023 and May 20, 2025, both dates inclusive (the “Class Period”), of the important November 12, 2025 lead plaintiff deadline. So what: If you purchased V.F. Corporation securitiesduring the Class Period you may

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/2598258/THE_ROSEN_LAW_FIRM_P_A_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”), of the important November 7, 2025 lead plaintiff deadline. So what: If you purchased Savara securitiesduring the Class Period you may be

Scroll to Top